ALB and triple-negative breast carcinoma: In a subcutaneous model of triple negative breast cancer, Barnes et al. showed significantly decreased MRI-derived tumor volume day 3 after treatment with albumin-bound paclitaxel, and significantly increased median ADC-values already at Day 1 post-treatment [12].